biotech
Bio-AnalystSupplement research
person

D-Ribose

Selected research topic

Nutrient status

Confirmed comparison evidence for this topic is limited. The findings below retain their study conditions.

Some publications still need interpretation checks and are kept separate from the findings below.

Publications for this topic
2
Human comparison publications
0
Publications needing review
2

The current data are insufficient to judge results for this topic.

Representative outcome and study details

Some findings are held for review

Some papers have not cleared source or result review, so their findings are not summarized yet.

No confirmed result is available to summarize with study conditions.

A distinct publication count is not available.

  • Those papers are not summarized until review is complete.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: Not yet rated

The 0.0 evidence score includes 3 independent human studies and 3 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, a meaningful share of null findings in the same benefit area.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 52

Papers linked to this topic 2 · distinct papers 2 · comparison findings need further review · papers needing additional review 2

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

    What the research found

    Unspecified measured outcome

    The study needs further checking before its result can be interpreted.

    Other evidence · Single ingredient · Patient group

    Between-group comparison

    Analysis coverage and paper counts

    1 paper · 1 measured outcome

    1 papers held from direction counts

    Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

    Unspecified measured outcome

    The study needs further checking before its result can be interpreted.

    Other evidence · Single ingredient · Unspecified population

    The comparison could not be confirmed.

    Analysis coverage and paper counts

    1 paper · 1 measured outcome

    1 papers held from direction counts

    Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

    How to read research findings

    How should I read research findings?

    Research guides

    Side effects and combination findings

    Findings from this ingredient alone are shown separately from those involving another supplement or medication.

    No reviewed caution rules are available yet. Reported caution findings are shown below.

    Review 1 combination findings and 0 findings that outperformed an ingredient alone.

    Findings to review with care

    Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

    Side effects reported with this ingredient alone

    Symptoms or adverse events reported in studies without another active ingredient.

    Cytotoxicity1 papers
    The review highlights potential negative effects of D‑ribose, including increased glycation and cytotoxicity, suggesting caution in its use.Human studies · Study type not identified

    Reported improvements with combinations

    Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

    Combinations with reported improvement

    The combination showed improvement, but each ingredient's contribution is unclear.

    크레아틴A double-blind RCT in 53 patients with ischemic heart disease found that a combination supplement containing D-ribose, creatine, and vitamins improved cardiac double product and exercise tolerance compared to placebo, though the authors note the surrogate measure requires further validation.